Agentic artificial intelligence in cognitive screening: A translational roadmap for dementia care

Abstract

Conventional dementia screening tools, whether paper tests or static artificial intelligence (AI) models, capture only a snapshot of cognition and need to be adminstered periodically. Yet decline is dynamic, shaped by environment, comorbidities, and life history. Current approaches rarely adapt, integrate feedback, or provide transparent reasoning that clinicians can trust. We propose agentic AI systems: modular agents built on large language models (LLMs) that collaborate, adapt, and mirror interdisciplinary care. The Cognitive Agent Lab exemplifies this framework, emphasizing functional aspects (inputs, outputs, workflows) and non-functional aspects (transparency, adaptivity, robustness, clinical alignment). Embedding reasoning and collaboration, agentic AI offers a roadmap toward more personalized and explainable cognitive health tools.

Introduction

Cognitive decline unfolds gradually and often unpredictably, shaped by an individual's medical history, coexisting health conditions, cultural background, and the influence of caregivers and social context. Yet most screening tools, whether standardized paper-and-pencil tests such as the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA), or more recent artificial intelligence (AI) classifiers, treat cognition as if it were a fixed snapshot in time. These approaches are rigid in format, shallow in interpretation, and largely blind to longitudinal patterns of change.

Periodic administration can make screening superficially dynamic, but most systems still fail in three essential ways. First, they do not adapt to individual patient goals, education, or cultural context. Second, they often ignore insights from caregivers and remain disconnected from emerging scientific evidence. Third, they provide opaque outputs that clinicians cannot easily interrogate, explain, or refine.

This contrast is illustrated in Table 1, which highlights the differences between static screening tools and agentic AI systems. Whereas traditional approaches operate passively and return fixed scores, agentic systems are designed to engage, question, and evolve, also see Figure 1.

Figure 1.

From static questionnaires to adaptive artificial intelligence (AI) screening. Traditional dementia screening tools, e.g., Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS), and Clinical Dementia Rating (CDR), assess cognitive function at a single timepoint using fixed protocols. The proposed Cognitive Agent Lab introduces a modular architecture of AI agents that interact, reason, and adapt; incorporating multi-modal inputs, caregiver feedback, and clinical knowledge to produce transparent, dynamic assessments.

Table 1.

Comparison of static screening tools and agentic AI systems.

Static Screening Tools	Agentic AI Systems
Fixed protocol, same for all patients	Adapts to patient goals, context, and progress
Single timepoint snapshot	Longitudinal, continuously updating
Opaque outputs	Transparent, explainable reasoning
No integration of caregiver feedback	Incorporates caregiver and clinician input
Predefined scoring logic	Revises assessments with new evidence
Isolated execution	Collaborative, interdisciplinary agent roles

To address these limitations, we propose a new class of cognitive health tools built on agentic AI systems. These frameworks are modular, explainable, and self-correcting. Inspired by recent advances in large language models (LLMs) and multi-agent architectures, we introduce the concept of a Cognitive Agent Lab, a team of AI agents that reflects the collaborative nature of clinical teams, as shown in Figure 1. These agents are capable of self-reflection, structured dialogue, and adaptation not only to patient data but also to evolving clinical goals and shifting evidence bases.

In the sections that follow, we describe the clinical motivation for this approach, outline the architecture of the Cognitive Agent Lab, expand on its functional and non-functional requirements, and present a roadmap for near-term research and translation.

Limitations of current screening approaches

Consider an older woman who struggles with the MoCA, not because of cognitive impairment, but because the clock-drawing task assumes cultural and educational familiarity that does not reflect her experience. Or imagine a retired engineer whose subtle executive dysfunction goes unnoticed by the MMSE, developed in 1975, which fails to capture the nuanced decline his family observes daily.

These cases highlight a broader challenge: most dementia screening tools, while clinically useful, were not designed to adjust dynamically to patient background, context, or evolving health status. These one-size-fits-all assessments risk under-detection in some individuals and over-interpretation in others.

To their credit, traditional screeners such as the MMSE and MoCA have provided decades of clinical value. Administered periodically, they offer a form of temporal monitoring. Yet, they consistently reveal three major limitations:

Limited personalization. Standardized formats often overlook variation in education, language, and cultural norms, which can bias results. Recent reviews highlight how cultural assumptions embedded in screening tools limit their validity across diverse populations. ¹

Contextual disconnect. Current approaches rarely incorporate caregiver observations, comorbidities, or environmental influences that shape day-to-day cognition.

Static interpretation. Tools produce fixed outputs that do not evolve with new scientific evidence or adapt in real time to individual patient needs. Studies note that despite adequate reliability, the specificity of tools such as the MoCA remains suboptimal, often necessitating further testing and creating diagnostic bottlenecks. ²

Even newer AI-based screeners tend to replicate these same shortcomings. Most models are trained on static datasets, evaluated on snapshot accuracy metrics, and deployed as opaque “black boxes.” They rarely support functional requirements such as clearly defined inputs and outputs, or non-functional requirements such as adaptivity, transparency, robustness, and clinical trustworthiness.

This is not a failure of intent, but of architecture. Existing systems were never designed to reason, self-correct, or engage in dialogue with clinicians. As dementia research increasingly emphasizes the importance of context-rich, continuous, and interdisciplinary care, screening technologies must evolve to meet those expectations. What is needed is a reimagining of AI's role in cognitive health, not as a static test or hidden classifier, but as an adaptive, collaborative partner in assessment.

Defining agentic AI

Imagine a screening system that does not simply classify a patient's performance but pauses to ask questions. A patient may appear to struggle with a working memory task—not because of cognitive decline, but due to age-related hearing loss. Instead of issuing a static score, the system asks: Should auditory bias be factored in? Has the patient's bilingual history been considered? What does the latest literature say about visuospatial decline in similar populations?

This is the essence of agentic AI systems that move beyond pattern recognition to engage in reasoning that resembles clinical deliberation. They adapt strategies over time, interact with domain experts, and reflect on their own conclusions. Unlike conventional models, agentic AI systems can surface ambiguity, weigh alternative explanations, and suggest appropriate next steps.

Agentic AI differs from traditional neural networks in several key ways:

Modular specialization. Each agent is optimized for a defined role such as linguistic analysis, scoring, or literature retrieval, while sharing a common memory and communication protocol.

Reasoning through interaction. Agents exchange hypotheses, challenge each other's assumptions, and synthesize evidence much like members of an interdisciplinary care team.

Goal-oriented adaptation. Instead of delivering fixed outputs, agents revise assessments in response to patient context, user feedback, or new scientific knowledge.

Transparent deliberation. Every step of the workflow is traceable, interpretable, and auditable by clinicians, supporting shared accountability and trust.

Crucially, these systems are not autonomous replacements for clinicians. They function as collaborators capable of highlighting subtle linguistic markers, ³ recommending overlooked assessments, or suggesting evidence-based alternatives. Their role is to extend and enrich human reasoning with context-aware, self-reflective intelligence.

As dementia care increasingly shifts toward personalized and proactive approaches, agentic AI offers a blueprint for the next generation of screening tools, ones that recognize cognition as a dynamic, context-rich phenomenon and provide responses that are equally adaptive and transparent.

The cognitive agent lab architecture

A clinical consultation rarely depends on a single perspective. The neuropsychologist interprets testing patterns, the speech-language pathologist analyzes fluency and discourse, the physician integrates medical history, and the caregiver provides observations of everyday function. Each perspective adds value, and their collaboration produces insights no single expert could achieve alone.

As shown in Figure 2, the Cognitive Agent Lab mirrors this interdisciplinary model through a modular AI architecture. Instead of relying on a single, monolithic model, it distributes responsibilities across specialized agents, each designed for a specific role in cognitive assessment. These agents reason collectively through structured interaction, exchange information through a shared memory space, and invite clinician input at every stage of the process.

Core agent roles include, but are not limited to:

Text processing agent — ingests transcripts and extracts features such as disfluencies, repetitions, content units, and lexical diversity.

Clinical linguist agent — performs syntactic, semantic, and discourse-level analysis, highlighting markers of cognitive-linguistic change.

Cognitive assessment agent — integrates linguistic and discourse features to generate screening-alignment scores, highlight uncertainty, and recommend additional probes.

Literature review agent — surfaces relevant scientific findings to ensure interpretations are evidence-based.

Scientific critic agent — evaluates assumptions, flags potential confounds (e.g., low education, bilingualism, depression), and suggests alternative explanations.

Human clinician interface — reviews the reasoning trace, contextualizes outputs with family and cultural knowledge, and makes the final judgment call.

Functional aspects include clearly defined inputs (e.g., transcripts, optional caregiver metadata), structured outputs (features, reasoning traces, evidence-linked recommendations), and communication protocols that enable agents to exchange hypotheses and refine interpretations.

Non-functional aspects include transparency (each step is auditable by clinicians), adaptivity (reasoning shifts with patient context or new evidence), robustness (stability with noisy or incomplete data), and clinical alignment (outputs structured for real-world decision-making).

This architecture fosters dynamic dialogue. One agent may detect semantic drift, prompting the Clinical Linguist to reanalyze discourse structure, while the Critic requests supporting evidence from the Literature Agent. The clinician can review the entire reasoning chain, approve or challenge outputs, and integrate additional context. Over time, the system learns not only from data but from its own reasoning processes, gradually improving its calibration, nuance, and alignment with clinical practice. (Figure 2)

Figure 2.

The Cognitive Agent Lab represents a paradigm shift from static screening protocols to dynamic, collaborative assessment. Six specialized AI agents: Text Processing Agent, Clinical Linguist Agent, Cognitive Assessment Agent, Literature Review Agent, Scientific Critic Agent, and Human Clinician Interface work together to process multi-modal inputs (e.g., transcripts, caregiver observations, metadata) through structured dialogue and iterative reasoning. Unlike traditional tools that produce static snapshots, this architecture supports transparent, adaptive assessments that evolve with patient context and scientific evidence.

From framework to function

Turning the Cognitive Agent Lab from concept to practice requires careful architectural design, deliberate training methodology, and evaluation criteria that extend beyond accuracy alone.

Agent architecture

Each agent must function autonomously within its role while interacting seamlessly with others. We envision agents built on LLM foundations, fine-tuned for specialized tasks such as text preprocessing, discourse analysis, assessment synthesis, or critique. Agents exchange information through structured prompts, shared memory spaces, or message-passing protocols. For example, a Text Processing Agent may extract disfluencies and repetitions from a transcript; the Cognitive Assessment Agent may interpret these features in the context of task expectations; and the Scientific Critic may review the preliminary interpretation, highlight potential confounds (such as low education or bilingualism), and request additional evidence from the Literature Agent.

Each output is structured and interpretable, such as annotated features, confidence levels, or citations, and feeds into a collaborative reasoning workflow. The result is not a single prediction, but a reasoning trace that clinicians can review, question, and refine.

Training methodology

Foundational models can be initialized on domain-relevant corpora, including:

Annotated transcripts from cognitively healthy and impaired populations (e.g., DementiaBank),

Clinical discourse from neuropsychological assessments,

Simulated caregiver–patient dialogues.

Refinement may involve reinforcement learning or human-in-the-loop correction, where the emphasis is not only on predictive accuracy but also on transparency, adaptivity, and alignment with clinical reasoning workflows. Recent work has shown that virtual laboratories for multi-agent LLMs can provide safe environments for agents to practice reasoning, challenge each other, and coordinate effectively ⁴ before being deployed in real-world settings.

Evaluation and benchmarking

Because these systems are designed to support clinicians rather than replace them, evaluation must extend beyond screeing scores. Agentic AI systems should be benchmarked along multiple dimensions:

Transparency: Can each agent explain its reasoning and cite supporting sources?

Adaptivity: Does the system revise its outputs when new context (e.g., education, bilingualism) or clinician input is introduced?

Clinical alignment: Are outputs interpretable and useful to practitioners?

Collaborative value: Does the system enhance efficiency, surface alternative explanations, or improve clinician confidence in screening outcomes?

We recommend an initial “sandbox” phase using synthetic case profiles to evaluate agent communication, reasoning chains, and self-correction strategies.^4–6 From there, a gradual progression into pilot testing with de-identified real-world transcripts can help validate the framework under noisy, clinically realistic conditions.

Research roadmap and opportunities

The rise of agentic AI creates fertile ground for advancing dementia screening and support tools. Virtual multi-agent laboratories where LLM-based agents reason, communicate, and self-correct in simulation are already being used in other domains and can be adapted to cognitive health.^4–6 These environments enable safe experimentation with division of labor, adaptive reasoning strategies, and human-in-the-loop feedback.

Several near-term opportunities stand out:

Multi-agent simulation with existing datasets. Public resources such as DementiaBank can be leveraged to prototype agent workflows. Different agents can specialize in transcript preprocessing, discourse analysis, evidence retrieval, or critique, allowing systematic study of collaboration and reasoning synergy.

Synthetic agent–clinician dialogues. By simulating structured interactions between agents and clinicians, researchers can test how well these systems adapt to feedback, surface uncertainty, and align with practitioner goals. Such simulations can also refine prompting strategies and evaluation rubrics.

Markovian and state-based reasoning. Borrowing from cognitive architectures, agents could use Markov Decision Processes (MDPs) to track evolving cognitive states across tasks or sessions. This would support adaptive assessment strategies, such as selecting the next task based on expected information gain rather than following a fixed sequence.

Responsive feedback loops. Agentic systems could experiment with adjusting task complexity, pacing, or providing supportive cues, offering new ways to observe how individuals engage over time and potentially surfacing subtle early markers of decline.

These directions are not speculative. The core building blocks, LLMs fine-tuned for role specialization, prompt-based coordination protocols, and simulated patient data, already exist in adjacent domains.^4–6 The challenge ahead is focused adaptation to dementia care, guided by ethical human-in-the-loop design and rigorous validation tailored to the unique requirements of cognitive screening.

Ethical and practical safeguards

Deploying agentic AI in dementia screening demands proactive attention to ethical and regulatory challenges. First, transparency must remain central: every agentic workflow will produce clinician-auditable reasoning traces, ensuring interpretability and reproducibility. Second, bias mitigation requires representative datasets, continuous fairness auditing, and mechanisms to flag uncertainty when data are demographically limited. Third, privacy protection will rely on encryption, local or edge processing, and, where applicable, federated or differential privacy frameworks to minimize data exposure. Fourth, consent should evolve toward dynamic, age-appropriate consent processes that clearly communicate AI's role to patients and caregivers. Fifth, accountability must be shared; clear audit logs and version control will enable traceability of each agent's contribution while keeping the clinician as final decision-maker. Finally, clinical alignment will be sustained through iterative co-design with healthcare professionals, regulatory review, and real-world pilot evaluation. Together, these principles ensure that agentic AI remains trustworthy, human-centered, and compliant with emerging standards in digital health ethics.

Conclusions

Dementia screening has relied for decades on surveys and tools that capture only fragments of a much larger and more complex process. While instruments such as the MMSE and MoCA remain valuable, they are limited by their static design and their inability to incorporate context, feedback, or new evidence. Even recent AI-based screeners often repeat these same shortcomings, producing outputs that are opaque and not easily adapted to individual circumstances.

Agentic AI offers a path forward. By distributing responsibilities across specialized agents that reason, critique, and collaborate while keeping the clinician firmly in the loop, this approach reframes cognitive assessment as a transparent and dynamic process. The Cognitive Agent Lab illustrates how such systems could operate in practice, combining functional requirements (clear inputs, structured outputs, shared workflows) with non-functional requirements (adaptivity, robustness, transparency, and alignment with clinical use).

Importantly, this vision is not speculative. Advances in large language models, multi-agent collaboration, and virtual laboratory simulations already show feasibility in other domains. The challenge now is to adapt these approaches to dementia care, evaluate them with real-world datasets, and embed ethical safeguards to ensure that they remain clinician-guided and patient-centered.

By embedding reasoning and collaboration into AI design, agentic systems can provide tools that are more responsive, explainable, and trustworthy. They can help shift dementia care away from static snapshots toward continuous, adaptive, and context-aware support for clinicians, caregivers, and patients alike.